BW-ch13.pdf

(4943 KB) Pobierz
451106315 UNPDF
Viral Hemorrhagic Fevers
Chapter 13
VIRAL HEMORRHAGIC FEVERS
PETER B. JAHRLING, P h D * ; AILEEN M. MARTY, MD ; and THOMAS W. GEISBERT, P h D
INTRODUCTION
HISTORY AND EPIDEMIOLOGY
AGENT CHARACTERISTICS
CLINICAL MANIFESTATIONS
PATHOGENESIS
DIAGNOSIS
MEDICAL MANAGEMENT
PREVENTION AND CONTROL
SUMMARY
* Director, National Institute of Allergies and Infectious Diseases, Integrated Research Facility, National Institutes of Health, 6700A Rockledge Drive,
Bethesda, Maryland 20892; formerly, Senior Research Scientist, US Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort
Detrick, Maryland
Senior National Security Advisor, Medical Instructor, Battelle Office of Homeland Security, Battelle Memorial Institute, Suite 601, 1550 Crystal Drive,
Arlington, Virginia 22202; formerly, Professor, Pathology and Emerging Infections, Uniformed Services University of the Health Sciences, 4301 Jones
Bridge Road, Bethesda, Maryland
Chief, Department of Viral Pathology and Ultrastructure, US Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, Fort Detrick,
Maryland 21702
271
 
Medical Aspects of Biological Warfare
INTRODUCTION
Viral hemorrhagic fever (VHF) is an acute febrile
syndrome characterized by systemic involvement,
which includes generalized bleeding in severe infec-
tions. Patients with VHF manifest combinations of
malaise, prostration, generalized signs of increased
vascular permeability, and coagulation abnormalities.
Although the more severely ill patients manifest bleed-
ing, this does not result in a life-threatening loss of
blood volume. To a certain extent, however, it indicates
damage to the vascular endothelium and is an index
of disease severity in specific target organs. Much of
the disease appears to be caused by dysregulation of
the innate immune response, although replication of
these hemorrhagic fever (HF) viruses in target cells
and tissues can directly contribute to the pathological
manifestations of VHF. Factors that may contribute to
this subversion of the host immune response include
the rapid infection and impairment of dendritic cells,
a sudden and enigmatic death of lymphocytes, and the
release of a variety of mediators from virus-infected
cells that subsequently alter vascular function and
trigger the coagulation disorders that epitomize these
infections.
The viral agents causing severe HF, which are
taxonomically diverse, are all single-stranded RNA
viruses that can infect humans through contact with
contaminated animal reservoirs or arthropod vectors.
Under natural conditions, these viruses cause signifi-
cant infectious diseases, although their geographical
ranges may be tightly circumscribed. The relatively
recent advent of jet travel coupled with human de-
mographics increase the opportunity for humans to
contract these infections; from time to time, sporadic
cases of VHF are exported from endemic areas to new
areas. Clinical and epidemiological data on VHFs are
sparse; outbreaks are sporadic and unexpected, and
typically develop in geographical areas where cultural
customs and logistical barriers encumber systematic
investigations.
Because many VHFs spread easily in hospitals to
patients and staff alike, causing high morbidity and
mortality, they gained public notoriety in the past
decade from the enormous interest and fear gener-
ated by the news media. Ebola, an HF virus with a
high case-fatality rate (near 90% in some outbreaks),
dramatic clinical presentation, and lack of effective
specific treatment, was highly publicized when a new
Ebola species was isolated in a suburb of Washington,
DC, in 1989. 1 Progress in understanding the genesis of
the pathophysiological changes that make Ebola and
other HF viral infections of humans so devastating has
been slow, primarily because special containment is
required to safely work with most of these viruses.
Many of the VHF agents are highly infectious by
aerosol. Most VHF agents are also stable as respirable
aerosols, which means that they satisfy at least one
criterion for weaponization, and some have potential
as biological terrorism and warfare threats. Most of
these agents replicate in cell culture to concentrations
sufficiently high to create a small terrorist weapon, one
suitable for introducing lethal doses of virus into the
air intake of an airplane or office building. Some rep-
licate to higher concentrations, with obvious potential
ramifications. Because the VHF agents cause serious
diseases with high morbidity and mortality, their
existence as endemic disease threats and as potential
biological warfare weapons suggests a formidable
potential impact on public health.
HISTORY AND EPIDEMIOLOGY
Natural Disease
a patient’s history of being in a rural locale is an im-
portant factor to consider when reaching a diagnosis.
Human-to-human spread is possible for most of the HF
viruses. The majority of person-to-person spread has
been attributed to direct contact with infected blood
and body fluids. Airborne transmission of VHF agents
appears to be an infrequent event, but cannot categori-
cally be excluded as a mode of transmission.
Under natural conditions members of the Arena-
viridae , Bunyaviridae , Filoviridae , and Flaviviridae (Table
13-1) that cause VHF have specific geographic distribu-
tion and diverse modes of transmission. Although the
natural reservoir for Filoviridae remains unknown, as a
group, the HF viruses are linked to the ecology of their
vectors or reservoirs, whether rodents or arthropods.
These characteristics have great significance not only
in the natural transmission cycle for arenaviruses and
bunyaviruses (rodents to humans) and for flaviviruses
(arthropods), but also in the potential for nosocomial
transmission. Most reservoirs tend to be rural, and
Arenaviridae
The name arena is derived from the Latin words
“arenosus” (sandy) and “arena” (sand) in recogni-
tion of the sand-like ribosomal contents of virions in
272
Viral Hemorrhagic Fevers
TABLE 13-1
VIRAL HEMORRHAGIC FEVERS OF HUMANS
Virus Family Virus
Disease
Natural Distribution
Source
Incubation (Days)
Genus
Arenaviridae
Arenavirus
Lassa
Lassa fever
West Africa
Rodent
5–16
Junin
Argentine HF
South America
Rodent
7–14
Machupo
Bolivian HF
South America
Rodent
9–15
Sabia
Brazilian HF
South America
Rodent
7–14
Guanarito
Venezuelan HF
South America
Rodent
7–14
Whitewater
Unnamed HF
North America
Rodent
Unknown
Arroyo
Bunyaviridae
Nairovirus
Crimean-Congo HF Crimean-Congo HF Africa, Central Asia, Eastern Tick
3–12
Europe, Middle East
Phlebovirus
Rift Valley fever
Rift Valley fever
Africa, Saudi Arabia, Yemen Mosquito
2–6
Hantavirus
Agents of HFRS
HFRS
Asia, Balkans, Europe *
Rodent
9–35
Filoviridae
Ebolavirus
Ebola
Ebola HF
Africa
Unknown
2–21
Marburgvirus Marburg
Marburg HF
Africa
Unknown
2–14
Flaviviridae
Flavivirus
Dengue
Dengue HF
Asia, Africa, Pacific, Americas Mosquito
Unknown
Yellow fever
Yellow fever
Africa, tropical Americas
Mosquito
3–6
Omsk HF
Omsk HF
Central Asia
Tick
2–9
Kyasanur forest
Kyasanur forest
India
Tick
2–9
disease
disease
HF: hemorrhagic fever; HFRS: hemorrhagic fever with renal syndrome
* The agents of hantavirus pulmonary syndrome were isolated in North America.
There are four species of Ebola: Zaire, Sudan, Reston, and Ivory Coast.
thin section under the electron microscope. The fam-
ily Arenaviridae contains a single genus, Arenavirus .
However, the arenaviruses are divided into an Old
World group (eg, Lassa virus) and a New World group
(South American and North American HF viruses)
by phylogenetic analysis of RNA and serology. The
New World complex is further divided into three
major clades: A, B, and C. All of the viruses caus-
ing HF belong to clade B. 2 Arenaviruses survive in
nature by a lifelong association with specific rodent
reservoirs. Rodents spread the virus to humans, and
outbreaks can usually be related to some perturbation
in the ecosystem that brings humans in contact with
rodents or material contaminated by rodent products.
Arenaviruses initiate infection in the nasopharyngeal
mucosa.
Lassa fever made a dramatic appearance in 1969
when an American nurse working at a modest mis-
sion station in Lassa, a small town in northeastern
Nigeria, became ill and started a chain of nosocomial
infections that extended from healthcare workers in
Africa to laboratory workers in the United States.
Lassa virus produces Lassa fever, a major febrile dis-
ease of West Africa that causes 10% to 15% of adult
febrile admissions to the hospital and perhaps 40%
of nonsurgical deaths. 3 Lassa virus infects 100,000 to
300,000 people annually in West Africa, kills 5,000 to
10,000, and leaves approximately 30,000 deaf. 3,4 Lassa
fever causes high mortality in pregnant women and
is also a pediatric disease. Most Lassa virus infections
are traceable to contact with the carrier rodent, the rat
( Mastomys natalensis) , but nosocomial transmission
is also possible. Lassa fever has periodically been
imported to Europe, the United States, Canada, and
Japan by travelers from West Africa. 5 Since 2000 at
least five fatal Lassa fever cases have occurred in the
United Kingdom, Germany, the Netherlands, and the
United States. 6,7
273
451106315.001.png
Medical Aspects of Biological Warfare
Argentine HF (AHF) was described in 1943, and
Junin virus was first isolated from one of its victims in
1958. Junin virus, which is carried by field voles such
as Calomys musculinus and Calomys laucha , is primarily
associated with agricultural activities in the pampas of
Argentina, where there have been 300 to 600 cases per
year since 1955. 8 Transmission is airborne from fomites,
contaminated food or water, or abrasions to the skin.
Direct person-to-person transmission is rare.
In 1959 physicians at the Beni department of Bolivia
noted a sporadic hemorrhagic illness in patients from
rural areas, which soon became known as Bolivian
HF. In 1963 Machupo virus was isolated from patients
with Bolivian HF, and shortly thereafter voles ( Calo-
mys callosus) were identified as the rodent reservoir. 9
Machupo virus produced several outbreaks of disease
in the 1960s, but more recently Bolivian HF has mani-
fested only sporadically; there was a cluster of cases in
1994. Transmission is through contaminated food and
water and direct contact through breaks in the skin;
there is only rare documentation of human-to-human
transmission.
In 1989 an outbreak of VHF involving several
hundred patients in the municipality of Guanarito,
Portuguesa state, Venezuela, led to the isolation of
Guanarito virus and identification of its probable ani-
mal reservoir, the cotton rat ( Sigmodon hispidus ). 10 Sabia
virus caused a fatal VHF infection in Brazil in 1990, 11
a severe laboratory infection in Brazil in 1992, and
another laboratory-acquired infection in the United
States in 1994. The most recently recognized arenavi-
rus linked to VHF is Whitewater Arroyo virus, which
apparently caused three fatal cases of HF in California
between 1999 and 2000. 12
1950–1951, an epizootic of RVF in Kenya resulted in
the death of about 100,000 sheep. An RVF epizootic can
lead to an epidemic among humans who are exposed
to diseased animals. Risk factors for human infection
include contact with infected blood, especially in
slaughterhouses, and handling of contaminated meat
during food preparation. Exposure to aerosols of RVF
virus is a potential source of infection for laboratory
workers. In 2000 RVF spread for the first time beyond
the African continent to Saudi Arabia and Yemen, af-
fecting both livestock and humans. 15
Crimean-Congo HF (CCHF) is a zoonotic disease
transmitted not only through the bite of at least 29 spe-
cies of ticks, of which Hyalomma marginatum is the most
important, but also by exposure to infected animals or
their carcasses, contact with blood and bodily secre-
tions of infected persons, and by aerosol. The agent
of CCHF is a Nairovirus . Although descriptions of this
illness can be traced to antiquity, this disease was first
recognized in 1944–1945 when a large outbreak oc-
curred in the Steppe region of western Crimea among
Soviet troops and peasants helping with the harvest.
In 1956 a similar illness was identified in a febrile
child from what was then the Belgian Congo (now the
Democratic Republic of the Congo), but it was not until
1969 that researchers realized that the pathogen caus-
ing Crimean HF was the same as that responsible for
the illness in the Congo. The linkage of the two place
names resulted in the current name for the disease
and the virus. CCHF is endemic in many countries in
Africa, Europe, and Asia; it causes sporadic, yet par-
ticularly severe, VHF in endemic areas. 16 CCHF is often
associated with small, hospital-centered outbreaks,
owing to the profuse hemorrhage and highly infective
nature of this virus in humans exposed by aerosol. An
HF outbreak on the Pakistani-Afghan border during
the 2001–2002 US campaign against terrorists is sus-
pected to have been caused by the CCHF virus, and
various media outlets have reported that CCHF was
confirmed by a laboratory in South Africa.
Hantaviruses, unlike other bunyaviruses, are not
transmitted by infected arthropods; rather, contact with
infected rodents and their excreta leads to most human
infections. However, person-to-person transmission
was described during a recent outbreak of hantavirus
pulmonary syndrome (HPS) in southwest Argentina, 17
and researchers have also documented transmission by
aerosol. 18 Of the more than 20 known types of hantavi-
ruses, at least nine (Hantaan, Seoul, Puumala, Dobrava,
Sin Nombre, New York, Black Creek Canal, Andes, and
Bayou) hantaviruses can cause significant clinical ill-
ness. Each virus has its own rodent vector, geographic
distribution, and clinical expression. The poor sanitary
conditions of combat promote exposure to rodents. A
Bunyaviridae
Of the five genera that comprise the family Bunya-
viridae , three genera contain viruses that cause HF: (1)
Phlebovirus (eg, Rift Valley fever virus); (2) Nairovirus
(eg, Crimean-Congo HF virus); and (3) Hantavirus (eg,
Hantaan virus). Bunyaviridae is transmitted by arthro-
pods (primarily mosquitoes, ticks, and phlebotomine
flies), or, as is the case for hantaviruses, by contact with
rodents or rodent products. Transmission by aerosol
is also documented.
The phlebovirus Rift Valley fever (RVF) virus,
which causes RVF, is a significant human pathogen.
Outbreaks of this major African disease often reflect
unusual increases in mosquito populations. 13 RVF
virus, which primarily affects domestic livestock,
can cause epizootic disease in domestic animals. RVF
was first described in 1931 as an enzootic hepatitis
among sheep, cattle, and humans in Kenya. 14 During
274
Viral Hemorrhagic Fevers
review of illness during the US Civil War, World War I,
and World War II suggests that outbreaks of hantaviral
infections occurred among troops. Hantaviral disease
was described in Manchuria along the Amur River,
and later among United Nations troops during the
Korean War, where it became known as Korean HF. 19
The prototype virus from this group, Hantaan, which
causes Korean HF with renal syndrome (HFRS), was
isolated in 1977. The reservoir host for Hantaan virus
is the striped field mouse ( Apodemus agrarius) .
Hantaan virus is still active in Korea, Japan, and
China. Seoul virus, which is carried mainly by the
house rat ( Rattus norvegicus) , causes a milder form of
HFRS and may be distributed worldwide. Other han-
taviruses associated with HFRS include the Puumala
virus, which is associated with bank voles ( Clethriono-
mys glareolus ). An epidemic in 1993 in the Four Corners
region of the United States led to the identification of
a new hantavirus (Sin Nombre virus), and eventually
to identification of several related viruses (Black Creek
Canal, New York, Andes, and Bayou); all of these have
been associated with HPS. 20,21 The classical features of
the syndrome of acute febrile illness associated with
prominent cardiopulmonary compromise have been
extended to clinical variants, including disease with
frank hemorrhage. 21
fatal cases among residents and travelers in southeast
Africa. In 1998–2000, an outbreak of Marburg HF in
Durba, Democratic Republic of the Congo, was linked
to individuals working in a gold mine. 23 In 2004–2005
there was a Marburg virus outbreak in Angola that
caused over 200 deaths (90% mortality). 24
Ebola viruses, taxonomically related to Marburg
viruses, were first recognized during near-simultane-
ous explosive outbreaks in 1976 in small communities
in the former Zaire (now the Democratic Republic
of the Congo) 25 and Sudan. 26 Reuse of unsterilized
needles and syringes and nosocomial contacts caused
significant secondary transmission. These independent
outbreaks involved serologically distinct viral species.
The Ebola-Zaire outbreak involved 318 cases and 280
deaths (88% mortality), and the Ebola-Sudan outbreak
involved 280 cases and 148 deaths (53% mortality).
Since 1976 Ebola virus has appeared sporadically in
Africa, causing several small- to mid-size outbreaks
between 1976 and 1979. In 1995 a large epidemic of
Ebola-Zaire HF involving 315 cases occurred, with an
81% case fatality rate, in Kikwit, a community in the
former Zaire. 27 Meanwhile, between 1994 and 1996, the
Ebola-Zaire virus caused smaller outbreaks in Gabon. 28
In 2000 Gulu, Uganda, suffered a large epidemic of
VHF attributed to the Sudan species of Ebola virus. 29
More recently, Gabon and the Republic of Congo suf-
fered small VHF outbreaks attributed to Ebola-Zaire
virus. The most recent outbreaks in Gabon and the
Republic of Congo also involved a catastrophic decline
in populations of great apes, which may have a role in
transmission to humans. 30,31
In 1989 a third species of Ebola virus appeared in
Reston, Virginia, in association with an outbreak of
VHF among cynomolgus monkeys ( Macaca fascicularis )
imported to the United States from the Philippine
Islands. 1 Hundreds of monkeys were infected (with
high mortality) in this episode, but no human cases
occurred, although four animal caretakers seroconver-
ted without overt disease. Epizootics in cynomolgus
monkeys recurred at other facilities in the United States
and Europe through 1992 and again in 1996. The lack
of human disease in these episodes suggests that the
Reston species of Ebola may be less pathogenic to hu-
mans, although the pathogenic potential in humans is
unknown. A fourth species of Ebola virus, Ivory Coast,
was identified in Côte d’Ivoire in 1994; this species was
associated with chimpanzees, and only one nonfatal
human infection was identified. 32
Little is known about the natural history of filovi-
ruses. Surveys in Central Africa of a variety of species
of animals and arthropods have yet to conclusively
identify a reservoir host. Laboratory studies have
shown that fruit and insectivorous bats can support
Filoviridae
Marburg virus and Ebola virus, the causative agents
of Marburg and Ebola HF, respectively, represent the
two genera that comprise the family Filoviridae . The
Marburgvirus genus contains a single species: Lake
Victoria marburgvirus . The Ebolavirus genus is divided
into four distinct species: (1) Ivory Coast ebolavirus , (2)
Reston ebolavirus , (3) Sudan ebolavirus , and (4) Zaire
ebolavirus . By electron microscopy, filoviruses have
a highly unusual filamentous appearance. The term
filovirus was derived from “filo,” which is Latin for
thread. Marburg virus was first recognized in 1967
when three simultaneous outbreaks of a lethal VHF
epidemic occurred at Marburg and Frankfurt, Ger-
many, and Belgrade, Yugoslavia, among laboratory
workers exposed to the blood and tissues of African
green monkeys ( Chlorocebus aethiops ) imported from
Uganda. Secondary transmission to medical person-
nel and family members was also documented. 22 A
clinician recognized the initial outbreak in Marburg. 22
Thirty-one patients became infected, and seven died.
The 23% human mortality and bizarre morphology of
the newly discovered virus had a great psychological
impact and led to new quarantine procedures for im-
ported animals. During the next two decades, Marburg
virus was associated with sporadic, isolated, usually
275
Zgłoś jeśli naruszono regulamin